1. Home
  2. NNVC vs HHS Comparison

NNVC vs HHS Comparison

Compare NNVC & HHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NNVC
  • HHS
  • Stock Information
  • Founded
  • NNVC 2005
  • HHS 1923
  • Country
  • NNVC United States
  • HHS United States
  • Employees
  • NNVC N/A
  • HHS N/A
  • Industry
  • NNVC Biotechnology: Pharmaceutical Preparations
  • HHS Advertising
  • Sector
  • NNVC Health Care
  • HHS Consumer Discretionary
  • Exchange
  • NNVC Nasdaq
  • HHS Nasdaq
  • Market Cap
  • NNVC 24.1M
  • HHS 27.3M
  • IPO Year
  • NNVC N/A
  • HHS N/A
  • Fundamental
  • Price
  • NNVC $1.42
  • HHS $3.64
  • Analyst Decision
  • NNVC
  • HHS
  • Analyst Count
  • NNVC 0
  • HHS 0
  • Target Price
  • NNVC N/A
  • HHS N/A
  • AVG Volume (30 Days)
  • NNVC 123.5K
  • HHS 9.2K
  • Earning Date
  • NNVC 09-26-2025
  • HHS 08-07-2025
  • Dividend Yield
  • NNVC N/A
  • HHS N/A
  • EPS Growth
  • NNVC N/A
  • HHS N/A
  • EPS
  • NNVC N/A
  • HHS N/A
  • Revenue
  • NNVC N/A
  • HHS $174,951,000.00
  • Revenue This Year
  • NNVC N/A
  • HHS $6.54
  • Revenue Next Year
  • NNVC N/A
  • HHS N/A
  • P/E Ratio
  • NNVC N/A
  • HHS N/A
  • Revenue Growth
  • NNVC N/A
  • HHS N/A
  • 52 Week Low
  • NNVC $0.94
  • HHS $3.06
  • 52 Week High
  • NNVC $1.92
  • HHS $7.72
  • Technical
  • Relative Strength Index (RSI)
  • NNVC 42.16
  • HHS 52.21
  • Support Level
  • NNVC $1.37
  • HHS $3.59
  • Resistance Level
  • NNVC $1.54
  • HHS $3.72
  • Average True Range (ATR)
  • NNVC 0.07
  • HHS 0.13
  • MACD
  • NNVC -0.01
  • HHS 0.01
  • Stochastic Oscillator
  • NNVC 32.91
  • HHS 37.14

About NNVC NanoViricides Inc.

Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.

About HHS Harte-Hanks Inc.

Harte-Hanks Inc is a customer experience company. The Company operates three business segments: Marketing Services; Customer Care; and Fulfillment & Logistics Services. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.

Share on Social Networks: